Inflammatory Bowel Disease 2 C1832321
Crohn's disease affecting the colon, causing abdominal pain, diarrhea, and fatigue. Managed with anti-inflammatory drugs, immune suppressants, and sometimes surgery.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- gastrointestinal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Bloody diarrhea
Toxic megacolon
Abdominal pain or nausea
(gastrointestinal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Urgency and tenesmus
(gastrointestinal)Abdominal cramping
(gastrointestinal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Aminosalicylates
Anti-inflammatory medications that target the lining of the digestive tract to reduce inflammation and manage symptoms. Typically prescribed for mild to moderate disease activity.
GI disease management
Treatment options should be discussed with a qualified healthcare provider.
Corticosteroids
Short-term anti-inflammatory medications used to induce remission during disease flares. Prescribed at the lowest effective dose for the shortest duration possible.
Additional treatment options
Low-Residue Diet
Dietary modification reducing fiber and undigested residue to decrease bowel inflammation and frequency of stools. Helps manage acute symptoms during flares.
dietaryStress Management
Techniques including mindfulness, meditation, and relaxation exercises to reduce stress triggers that may exacerbate symptoms.
lifestyleRegular Endoscopic Surveillance
Periodic colonoscopic evaluation to assess disease extent, monitor for dysplasia, and evaluate treatment response.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Inflammatory Bowel Disease 2 C1832321?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Torres J, Bonovas S, Doherty G, et al. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. J Crohns Colitis. 2020.
Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012.
Chrubasik CA, Boer L, Bosch TA, et al. Comparative Efficacy of Biologics in Ulcerative Colitis: A Network Meta-Analysis. Gastroenterology. 2021.
Sands BE, Sandborn WJ, Panaccione R, et al. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2013.
Medication Comparisons
Compare medications used to treat Inflammatory Bowel Disease 2 C1832321. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy